Natural Product Communications is an esteemed open-access journal published by SAGE Publications Inc, dedicated to the exploration and dissemination of knowledge concerning natural products in diverse fields, including Complementary and Alternative Medicine, Drug Discovery, and Pharmacology. Since its inception in 2006 and continuing through its converged years until 2024, the journal has gained recognition with a robust focus on plant science and the medicinal properties of natural products. With a commendable impact factor reflected in its category quartiles (Q3 across key domains), Natural Product Communications serves as a vital resource for researchers and professionals who aim to further the understanding of the therapeutic potential of natural compounds. As an open-access journal since 2020, it ensures wide accessibility to its published research, thereby facilitating collaboration and innovation within the scientific community. This commitment to excellence makes Natural Product Communications a crucial platform for advancing research in the holistic and pharmacological sciences.

Marine Drugs is a leading peer-reviewed journal dedicated to the field of drug discovery and development derived from marine resources. Published by MDPI in Switzerland since 2003, this open-access journal has established itself as a prominent platform for the dissemination of high-quality research, evidenced by its Q1 rankings in 2023 across multiple categories including Drug Discovery, Pharmaceutical Science, and Pharmacology, Toxicology, and Pharmaceutics. With a global readership, Marine Drugs specializes in the exploration of bioactive compounds from marine organisms, advancing our understanding of natural product chemistry and its applications in pharmacology and therapeutics. The journal actively encourages submissions from researchers worldwide, showcasing innovative studies, reviews, and methodologies that contribute to the growing field of marine biotechnology. Researchers, professionals, and students alike will find Marine Drugs an invaluable resource for enhancing their knowledge and fostering collaborations in marine drug research.

Chemistry of Natural Compounds is a premier academic journal dedicated to the intersection of natural products and modern chemistry, published by Springer. Since its inception in 1965, this journal has published innovative research articles, reviews, and discussions that focus on the chemistry and biochemistry of natural compounds, with an emphasis on their applications in various fields including medicine, agriculture, and environmental science. Recognized for its contributions to the scientific community, the journal is indexed in key databases and holds a respectable impact factor that underscores its relevance in the academic landscape. Currently ranked in the Q3 category across multiple disciplines, including Biochemistry, Genetics and Molecular Biology, Chemistry, and Plant Science, it serves as a critical resource for researchers and professionals aiming to deepen their understanding of the complex interactions between natural compounds and biological systems. While not an open-access journal, Chemistry of Natural Compounds provides valuable insights and essential findings that can aid in advancing both theoretical and applied sciences for researchers, students, and industry practitioners alike.

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.

Fitoterapia is a prestigious journal published by Elsevier that specializes in the fields of drug discovery and pharmacology. Established in 1948 and featuring a comprehensive scope that encompasses all aspects of medicinal plants and their derivatives, this journal is a critical resource for researchers, professionals, and students interested in the pharmacological effects of natural products. With an impressive impact factor reflected in its Q2 ranking in both Drug Discovery and Medicine as well as a Q3 ranking in Pharmacology, Fitoterapia plays a vital role in promoting innovative research in the intersection of traditional medicine and modern pharmacological science. The journal’s commitment to quality is further highlighted by its rankings in Scopus, where it holds a notable position among peers in its field. Although Fitoterapia does not currently offer Open Access, its reputation for rigor and relevance makes it an indispensable asset for anyone engaged in herbal medicine research and development. Authors and researchers seeking to publish groundbreaking findings will find a welcoming platform to disseminate their work in this influential journal.

ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C - A JOURNAL OF BIOSCIENCES, published by Walter de Gruyter GmbH, stands as a significant contribution to the field of biochemistry, genetics, and molecular biology. With an ISSN of 0939-5075 and an E-ISSN of 1865-7125, this esteemed journal has been disseminating critical research since its inception in 1973 and will continue to do so through 2024. As a recognized leader in its category, the journal holds a Q3 rank in the comprehensive field of biochemistry, genetics, and molecular biology, placing it in the 57th percentile according to Scopus rankings. While it operates under a traditional subscription model, this publication serves as a vital repository of high-quality, peer-reviewed articles that illuminate new discoveries and ongoing innovations within biosciences. Researchers, professionals, and students alike will find valuable insights and cutting-edge research within its pages, making it an essential resource for anyone serious about advancing their understanding in this dynamic field.

Jundishapur Journal of Natural Pharmaceutical Products, published by BRIEFLAND in the Netherlands, serves as a pivotal platform for researchers and professionals in the realm of pharmacology and toxicology. With its ISSN 1735-7780 and E-ISSN 2228-7876, the journal has established itself since its inception in 2011, showcasing a commitment to advancing knowledge in natural pharmaceutical products through innovative research. In 2023, it earned a commendable ranking in the Q3 category for Pharmacology, Toxicology, and Pharmaceutics, reflecting its contribution to the field as evidenced by its position in the Scopus rankings. The journal aims to publish high-quality research articles, reviews, and case studies that explore the potential benefits and toxicological aspects of natural products. Although it currently does not offer open access, its rigorous peer-review process ensures that only impactful studies are disseminated, ultimately facilitating a deeper understanding of natural pharmaceutical innovations. For those engaged in this exciting and evolving field, Jundishapur Journal of Natural Pharmaceutical Products is an essential resource that not only expands scholarly discourse but also promotes safe practices in natural product utilization.

JOURNAL OF NATURAL PRODUCTS, published by the American Chemical Society, is a premier academic journal that focuses on the study and application of natural products in various scientific domains. With an esteemed ISSN of 0163-3864 and an E-ISSN of 1520-6025, this journal caters to a wide range of fields, including Analytical Chemistry, Complementary and Alternative Medicine, Drug Discovery, Molecular Medicine, Organic Chemistry, Pharmaceutical Science, and Pharmacology. The journal consistently ranks in the Q1 and Q2 quartiles across these categories, reflecting its significant contribution and rigorous standards in the scientific community. Notably, its Scopus rankings highlight its influence, with notable percentiles across various fields, including a 93rd percentile in Complementary and Alternative Medicine. The JOURNAL OF NATURAL PRODUCTS aims to advance knowledge in the field by publishing groundbreaking research articles, reviews, and critical insights, making it an essential resource for researchers, professionals, and students dedicated to exploring the vast potential of natural substances. This journal addresses complex challenges and fosters innovative developments, further establishing its place as a cornerstone in natural products research. Access to published articles may vary, underscoring the need for individuals in this field to stay connected with the latest advances through the journal's offerings.

Journal of Natural Medicines, published by SPRINGER JAPAN KK, is a leading academic journal that plays a pivotal role in the advancement of research in the fields of Complementary and Alternative Medicine, Drug Discovery, Molecular Medicine, Organic Chemistry, and Pharmaceutical Science. Established in 1994 and set to continue until 2024, this journal serves as a vital conduit for the dissemination of groundbreaking research and innovative ideas that bridge traditional medicinal knowledge and modern scientific inquiry. With its impressive ranking in Scopus—ranking #12 out of 105 in Complementary and Alternative Medicine and holding a Q1 category quartile for 2023—it stands as a reputable source for high-quality, peer-reviewed articles. The journal's commitment to excellence is further underscored by its inclusion in the Springer network, providing researchers, professionals, and students with valuable insights and the latest developments in natural medicines. Although this journal operates under a subscription model, its profound impact on these interdisciplinary fields makes it an essential resource for anyone engaged in the study or practice of natural medicinal therapies.

The Journal of Ethnopharmacology, published by Elsevier Ireland Ltd, is a pivotal resource in the fields of Drug Discovery and Pharmacology, recognized as a Q1 journal in both categories as of 2023. With a rich history since its inception in 1979, this peer-reviewed journal provides a platform for rigorous research and innovative findings related to traditional medicinal practices and the therapeutic potential of natural products. The journal is ISSN 0378-8741 and E-ISSN 1872-7573, and it plays a vital role in advancing knowledge through its high-quality publications, which rank impressively at #35 out of 313 in Pharmacology and #19 out of 157 in Drug Discovery according to Scopus metrics. Although not open access, the journal aims to cater to a diverse audience of researchers, professionals, and students dedicated to exploring the intersection of ethnopharmacology and modern scientific inquiry. Its comprehensive scope encapsulates a multitude of studies spanning the globe, fostering a deeper understanding of how traditional practices can inform contemporary health solutions.